Kimberly Ann Cotton, PMHNP
Psychiatric/Mental Health · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kimberly Ann Cotton’s office at (888) 995-2230 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington ARNP.AP.60835480-NPAdvanced Registered Nurse Practitioner License · since 2018 · expires 2027-02-05ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$5,902
Medicare paid this office $5,902 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 12 | $5,456 | $68 |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 50 · 85 and older 0% · Health risk score 1.08. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $36,255, Medicare allowed $7,960 and paid $5,902; for 91 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 91 | 50 | 1.08 | $36,255 | $5,902 |
| 2023 | 12 | 52 | 49 | 0.98 | $17,202 | $3,097 |
| 2021 | 15 | 35 | 62 | 3.03 | $8,246 | $1,776 |
| 2020 | 26 | 28 | 66 | 2.72 | $10,108 | $2,412 |
| 2019 | 16 | 18 | 67 | 2.43 | $5,387 | $974 |
| 2018 | 46 | 63 | 51 | 1.31 | $8,264 | $2,143 |
| 2017 | 29 | 80 | 56 | 1.18 | $4,437 | $2,957 |
| 2016 | 34 | 58 | 47 | 1.22 | $10,520 | $2,862 |
| 2015 | 26 | 48 | 52 | 1.04 | $8,800 | $2,406 |
| 2014 | 28 | 41 | 53 | 1.11 | $7,806 | $2,134 |
| 2013 | 47 | 74 | 52 | 1.38 | $9,016 | $2,099 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2020: 1 service
| Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 11 | $1,021 | $93 |
2018: 2 services
| Psychiatric diagnostic evaluation | 11 | $924 | $84 |
| Short return visit (20+ min) | 19 | $206 | $9 |
2017: 2 services
| Short return visit (20+ min) | 25 | $1,353 | $31 |
| Return visit (30+ min) | 15 | $1,187 | $49 |
2016: 2 services
| Psychiatric diagnostic evaluation with medical services | 14 | $1,209 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,170 | $38 |
2015: 1 service
| Psychiatric diagnostic evaluation with medical services | 11 | $1,000 | $91 |
2014: 1 service
| Return visit (30+ min) | 23 | $1,487 | $46 |
2013: 1 service
| Return visit (30+ min) | 46 | $2,032 | $32 |
Medicaid work
$648,485 in 2024
Medicaid paid $648,485 for 2,027 billed services this clinician did in 2024, up to 98 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,229 | $358,684 |
| Long return visit (40+ min) | 458 | $152,043 |
| Psychiatric diagnostic evaluation with medical services | 208 | $86,164 |
| Short return visit (20+ min) | 132 | $51,593 |
| 2024 | 2,027 | 4 | 98 | $648,485 |
| 2023 | 2,177 | 4 | 94 | $433,837 |
| 2022 | 1,898 | 5 | 93 | $339,301 |
| 2021 | 1,307 | 4 | 75 | $217,113 |
| 2020 | 422 | 3 | 60 | $84,719 |
| 2018 | 42 | 2 | 17 | $1,064 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,035 | $170,121 |
| Long return visit (40+ min) | 421 | $120,002 |
| Psychiatric diagnostic evaluation with medical services | 298 | $96,137 |
| Short return visit (20+ min) | 423 | $47,576 |
2022
| Return visit (30+ min) | 1,140 | $168,524 |
| Long return visit (40+ min) | 320 | $85,846 |
| Psychiatric diagnostic evaluation with medical services | 207 | $69,750 |
| Short return visit (20+ min) | 112 | $10,806 |
| OFF/OP EST MAY X REQ PHY/QHP | 119 | $4,375 |
2021
| Return visit (30+ min) | 959 | $142,788 |
| Long return visit (40+ min) | 125 | $33,310 |
| Psychiatric diagnostic evaluation with medical services | 78 | $26,411 |
| Short return visit (20+ min) | 145 | $14,605 |
2020
| Return visit (30+ min) | 262 | $42,795 |
| Long return visit (40+ min) | 148 | $37,856 |
| Psychiatric diagnostic evaluation with medical services | 12 | $4,068 |
2018
| PSYCH DIAGNOSTIC EVALUATION | 30 | $556 |
| Short return visit (20+ min) | 12 | $509 |
Drugs they prescribed that Part D paid
$109,072
Pharmacies billed $109,072 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,012 generic and 35 brand-name prescriptions · $109,072 in drug cost · 26 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 20 | $28,146 | $1,407 |
| Asenapine Maleate | 11 | $2,770 | $252 |
| Aripiprazole | 38 | $2,475 | $65 |
| Vilazodone | 11 | $1,586 | $144 |
| Bupropion | 12 | $1,353 | $113 |
See all 39 drugs
| Vraylar | 20 | $28,146 | $1,407 |
| Asenapine Maleate | 11 | $2,770 | $252 |
| Aripiprazole | 38 | $2,475 | $65 |
| Vilazodone | 11 | $1,586 | $144 |
| Bupropion | 12 | $1,353 | $113 |
| Gabapentin | 61 | $1,054 | $17 |
| Duloxetine | 74 | $963 | $13 |
| Bupropion Xl | 37 | $876 | $24 |
| Ziprasidone | 38 | $851 | $22 |
| Buspirone | 67 | $824 | $12 |
| Dextroamphetamine-Amphetamine | 12 | $724 | $60 |
| Clonazepam | 58 | $640 | $11 |
| Chlorpromazine | 13 | $625 | $48 |
| Oxcarbazepine | 13 | $581 | $45 |
| Venlafaxine Hcl Er | 33 | $553 | $17 |
| Prazosin | 12 | $466 | $39 |
| Olanzapine | 19 | $380 | $20 |
| Hydroxyzine | 33 | $354 | $11 |
| Desvenlafaxine Succinate Er | 11 | $294 | $27 |
| Doxepin | 11 | $255 | $23 |
| Mirtazapine | 18 | $243 | $13 |
| Sertraline | 29 | $233 | $8 |
| Divalproex Sodium Er | 12 | $200 | $17 |
| Quetiapine | 21 | $189 | $9 |
| Escitalopram | 22 | $185 | $8 |
| Quetiapine Fumarate Er | 20 | $179 | $9 |
| Propranolol Hcl Er | 11 | $175 | $16 |
| Topiramate | 14 | $166 | $12 |
| Hydroxyzine Pamoate | 23 | $162 | $7 |
| Benztropine Mesylate | 11 | $128 | $12 |
| Diazepam | 23 | $126 | $5 |
| Trazodone | 46 | $115 | $2 |
| Lamotrigine | 24 | $97 | $4 |
| Lorazepam | 21 | $76 | $4 |
| Fluoxetine | 12 | $58 | $5 |
| Zolpidem Tartrate Er | 12 | $58 | $5 |
| Paroxetine | 15 | $56 | $4 |
| Zolpidem | 11 | $48 | $4 |
| Risperidone | 13 | $43 | $3 |
Year by year
| 2024 | 1,047 | 42 | None | 3% | $109,072 |
| 2023 | 748 | 49 | None | 5% | $76,220 |
| 2022 | 752 | 72 | 0% (0) | 7% | $129,076 |
| 2021 | 1,137 | 100 | 0% (0) | 8% | $163,349 |
| 2020 | 222 | 54 | 0% (0) | 6% | $14,280 |
| 2019 | 38 | None | 0% (0) | 0% | $2,020 |
| 2018 | 446 | 53 | 0% (0) | 12% | $36,799 |
| 2017 | 712 | 50 | 0% (0) | 9% | $37,752 |
| 2016 | 15 | None | 0% (0) | None | $199 |
| 2015 | 41 | 14 | 0% (0) | None | $4,440 |
| 2014 | 493 | 50 | None | 21% | $58,663 |
| 2013 | 815 | 63 | None | 23% | $106,172 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Chlorpromazine | 11 | $5,257 | $478 |
| Aripiprazole | 27 | $4,741 | $176 |
| Ziprasidone | 34 | $1,848 | $54 |
| Methylphenidate Er | 17 | $1,669 | $98 |
| Bupropion | 19 | $1,486 | $78 |
| Dextroamphetamine-Amphetamine | 13 | $1,310 | $101 |
| Gabapentin | 51 | $1,224 | $24 |
| Prazosin | 25 | $1,148 | $46 |
| Buspirone | 41 | $807 | $20 |
| Oxcarbazepine | 11 | $799 | $73 |
| Quetiapine | 27 | $544 | $20 |
| Duloxetine | 34 | $496 | $15 |
| Clonazepam | 29 | $443 | $15 |
| Bupropion Xl | 32 | $419 | $13 |
| Hydroxyzine | 17 | $343 | $20 |
| Quetiapine Fumarate Er | 19 | $265 | $14 |
| Trazodone | 32 | $264 | $8 |
| Divalproex Sodium Er | 12 | $260 | $22 |
| Venlafaxine Hcl Er | 17 | $231 | $14 |
| Escitalopram | 24 | $181 | $8 |
| Sertraline | 25 | $176 | $7 |
| Mirtazapine | 14 | $134 | $10 |
| Lorazepam | 13 | $66 | $5 |
2022: 24 drugs
| Latuda | 23 | $41,927 | $1,823 |
| Invega Sustenna | 11 | $35,907 | $3,264 |
| Aripiprazole | 26 | $9,599 | $369 |
| Chlorpromazine | 20 | $6,156 | $308 |
| Divalproex Sodium Er | 14 | $1,787 | $128 |
| Dextroamphetamine-Amphet Er | 17 | $1,591 | $94 |
| Quetiapine | 45 | $1,223 | $27 |
| Gabapentin | 69 | $1,196 | $17 |
| Ziprasidone | 20 | $928 | $46 |
| Venlafaxine Hcl Er | 19 | $788 | $41 |
| Bupropion Xl | 19 | $694 | $37 |
| Duloxetine | 40 | $596 | $15 |
| Bupropion | 12 | $554 | $46 |
| Mirtazapine | 19 | $415 | $22 |
| Doxepin | 27 | $413 | $15 |
| Clonazepam | 21 | $391 | $19 |
| Hydroxyzine Pamoate | 27 | $379 | $14 |
| Prazosin | 16 | $336 | $21 |
| Lamotrigine | 47 | $291 | $6 |
| Buspirone | 24 | $289 | $12 |
| Trazodone | 34 | $211 | $6 |
| Risperidone | 13 | $72 | $6 |
| Escitalopram | 11 | $61 | $6 |
| Fluoxetine | 15 | $31 | $2 |
2021: 27 drugs
| Latuda | 28 | $47,935 | $1,712 |
| Invega Sustenna | 13 | $37,591 | $2,892 |
| Vraylar | 17 | $21,616 | $1,272 |
| Aripiprazole | 37 | $3,072 | $83 |
| Duloxetine | 153 | $2,193 | $14 |
| Bupropion Xl | 39 | $1,766 | $45 |
| Venlafaxine Hcl Er | 22 | $1,764 | $80 |
| Quetiapine | 115 | $1,427 | $12 |
| Ziprasidone | 12 | $760 | $63 |
| Gabapentin | 61 | $653 | $11 |
| Prazosin | 33 | $471 | $14 |
| Hydroxyzine Pamoate | 21 | $412 | $20 |
| Lamotrigine | 75 | $410 | $5 |
| Olanzapine | 18 | $403 | $22 |
| Trazodone | 63 | $402 | $6 |
| Mirtazapine | 46 | $364 | $8 |
| Hydroxyzine | 26 | $335 | $13 |
| Doxepin | 13 | $293 | $23 |
| Buspirone | 28 | $243 | $9 |
| Lorazepam | 18 | $201 | $11 |
| Benztropine Mesylate | 16 | $180 | $11 |
| Risperidone | 29 | $143 | $5 |
| Sertraline | 12 | $85 | $7 |
| Escitalopram | 12 | $78 | $6 |
| Amitriptyline | 16 | $69 | $4 |
| Lithium Carbonate | 14 | $29 | $2 |
| Fluoxetine | 17 | $13 | $1 |
2020: 6 drugs
| Duloxetine | 36 | $744 | $21 |
| Quetiapine | 23 | $589 | $26 |
| Prazosin | 11 | $379 | $34 |
| Gabapentin | 11 | $215 | $20 |
| Mirtazapine | 12 | $156 | $13 |
| Trazodone | 13 | $116 | $9 |
2018: 15 drugs
| Saphris | 13 | $11,168 | $859 |
| Aripiprazole | 11 | $1,631 | $148 |
| Haloperidol Decanoate 100 | 18 | $1,390 | $77 |
| Duloxetine | 15 | $462 | $31 |
| Oxcarbazepine | 11 | $447 | $41 |
| Quetiapine | 26 | $295 | $11 |
| Gabapentin | 16 | $241 | $15 |
| Mirtazapine | 32 | $192 | $6 |
| Trazodone | 23 | $180 | $8 |
| Escitalopram | 16 | $163 | $10 |
| Benztropine Mesylate | 19 | $130 | $7 |
| Fluoxetine | 20 | $118 | $6 |
| Lamotrigine | 14 | $110 | $8 |
| Buspirone | 11 | $106 | $10 |
| Sertraline | 19 | $98 | $5 |
2017: 24 drugs
| Saphris | 11 | $8,794 | $799 |
| Haloperidol Decanoate 100 | 28 | $2,373 | $85 |
| Aripiprazole | 13 | $1,398 | $108 |
| Memantine | 18 | $1,139 | $63 |
| Duloxetine | 37 | $974 | $26 |
| Fluvoxamine Maleate | 15 | $917 | $61 |
| Oxcarbazepine | 17 | $802 | $47 |
| Quetiapine | 62 | $575 | $9 |
| Benztropine Mesylate | 40 | $393 | $10 |
| Bupropion Xl | 12 | $354 | $30 |
| Mirtazapine | 44 | $346 | $8 |
| Propranolol | 18 | $266 | $15 |
| Divalproex | 14 | $251 | $18 |
| Sertraline | 47 | $238 | $5 |
| Gabapentin | 19 | $238 | $13 |
| Risperidone | 23 | $233 | $10 |
| Lamotrigine | 14 | $205 | $15 |
| Trazodone | 28 | $200 | $7 |
| Fluoxetine | 32 | $192 | $6 |
| Escitalopram | 19 | $179 | $9 |
| Doxepin | 14 | $164 | $12 |
| Olanzapine | 15 | $146 | $10 |
| Citalopram Hbr | 15 | $120 | $8 |
| Topiramate | 11 | $55 | $5 |
2014: 15 drugs
| Latuda | 11 | $11,171 | $1,016 |
| Depakote Er | 11 | $4,803 | $437 |
| Duloxetine | 14 | $3,451 | $247 |
| Gabapentin | 17 | $691 | $41 |
| Bupropion Xl | 12 | $687 | $57 |
| Alprazolam | 59 | $589 | $10 |
| Escitalopram | 12 | $566 | $47 |
| Quetiapine | 14 | $428 | $31 |
| Zolpidem | 36 | $229 | $6 |
| Trazodone | 18 | $182 | $10 |
| Sertraline | 16 | $160 | $10 |
| Temazepam | 23 | $158 | $7 |
| Clonazepam | 19 | $152 | $8 |
| Diazepam | 13 | $90 | $7 |
| Citalopram Hbr | 15 | $77 | $5 |
2013: 27 drugs
| Modafinil | 17 | $20,371 | $1,198 |
| Abilify | 14 | $12,791 | $914 |
| Latuda | 12 | $8,240 | $687 |
| Cymbalta | 24 | $7,453 | $311 |
| Depakote Er | 14 | $5,717 | $408 |
| Ziprasidone | 12 | $3,643 | $304 |
| Lyrica | 11 | $2,497 | $227 |
| Escitalopram | 26 | $1,660 | $64 |
| Venlafaxine Hcl Er | 26 | $1,137 | $44 |
| Quetiapine | 17 | $1,081 | $64 |
| Bupropion Xl | 17 | $1,011 | $59 |
| Gabapentin | 18 | $897 | $50 |
| Alprazolam | 89 | $871 | $10 |
| Temazepam | 53 | $481 | $9 |
| Topiramate | 28 | $366 | $13 |
| Zolpidem | 58 | $321 | $6 |
| Trazodone | 30 | $316 | $11 |
| Clonazepam | 33 | $301 | $9 |
| Mirtazapine | 19 | $252 | $13 |
| Lorazepam | 18 | $237 | $13 |
| Risperidone | 13 | $233 | $18 |
| Zonisamide | 11 | $212 | $19 |
| Sertraline | 15 | $173 | $12 |
| Citalopram Hbr | 28 | $155 | $6 |
| Diazepam | 16 | $140 | $9 |
| Baclofen | 11 | $99 | $9 |
| Fluoxetine | 11 | $46 | $4 |
Money from drug and device companies
$58 in 2025
| 2025 | 2 | 2 | None | $58 |
| 2024 | 1 | 1 | None | $27 |
| 2021 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Abilify Maintena | $29 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $29 | 1 payment
|
See all 2 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-27 | Caplyta | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-08-26 | Abilify Maintena | $29 |
See earlier years (2024, 2021)
2024: $27
| E.R. Squibb & Sons L.L.C. | Cobenfy | $27 | 1 payment
|
2021: $12
| EMD Serono | None | $12 | 1 payment
|
Professional record
- NPI
- 1194757385
- Licence
- MN 5579, MO 2018026394, OR 201802038NP-PP, TX 0372662-34, WA AP60835480, WI 8141-33Washington ARNP.AP.60835480-NP: Active
More record details
- Sole proprietor
- Yes
- Medicaid ID
- TX 1782260
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 5308 Vale St, Greenville, TX, 75402
- NPI first listed
- 2006-07-07
- NPI last updated
- 2021-02-23
- NPI record certified
- 2021-02-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN, 55433 · 2505 Mission Dr, Jefferson City, MO, 65109 · 700 S Park St, Madison, WI, 53715 · 1015 Nw 22nd Ave, Portland, OR, 97210 · 1629 E Division St, River Falls, WI, 54022 · 2211 Ne 139th St, Vancouver, WA, 98686
This office lists an electronic records connection.